CN101390985B - Traditional Chinese medicine for treating diabetes acral necrosis - Google Patents

Traditional Chinese medicine for treating diabetes acral necrosis Download PDF

Info

Publication number
CN101390985B
CN101390985B CN2007101221139A CN200710122113A CN101390985B CN 101390985 B CN101390985 B CN 101390985B CN 2007101221139 A CN2007101221139 A CN 2007101221139A CN 200710122113 A CN200710122113 A CN 200710122113A CN 101390985 B CN101390985 B CN 101390985B
Authority
CN
China
Prior art keywords
chinese medicine
radix
diabetes
ganoderma
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2007101221139A
Other languages
Chinese (zh)
Other versions
CN101390985A (en
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rugao Fu Steel Machinery Fittings Co., Ltd.
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2007101221139A priority Critical patent/CN101390985B/en
Publication of CN101390985A publication Critical patent/CN101390985A/en
Application granted granted Critical
Publication of CN101390985B publication Critical patent/CN101390985B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is a Chinese traditional medicine for curing diabetes acral necrosis, which belongs to the diabetes curing Chinese traditional medicine and has purpose of fine curative effect and immediate effect; the medicine is composed of following raw materials: herba artemisiae, rhizomadrynariae, panax notoginseng, frankincense, myrrh, angelica, achyranthes, glossy ganoderma, Reishi Mushroom Powder, centella asiatica and rehmanniae radix; the Chinese traditional medicine has the advantages of supplementing qi and nourishing Blood, promoting Blood circulation so as to remove Blood stasis, reducing swelling and alleviating pain, and obvious activation and immediate effect for curing the diabetes acral necrosis.

Description

A kind of Chinese medicine for the treatment of acromegaly necrosis diabetes
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of acromegaly necrosis diabetes, belong to a kind of treatment diabetes Chinese medicine.
Technical background
The Western medicine and the Chinese medicine that are used for the treatment of acromegaly necrosis diabetes at present exist some significantly not enough: the one, and DeGrain; The 2nd, it is slower to take effect.A large amount of patients feel simply helpless in the face of acromegaly necrosis diabetes, suffer from the limb obstinate, constantly worsen, and the amputation of being compelled to do is at last handled.
At above problem, the invention provides the Chinese medicine of a kind of benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, effective, instant effect, it can solve, and to treat the Chinese medicine effect obvious inadequately in the past, and the slower problem that takes effect has that drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine that is used for the treatment of acromegaly necrosis diabetes adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Herba Artemisiae Anomalae 2---15 parts of 12 parts of Rhizoma Drynariae 2---15 portions of Radix Notoginseng 2---
Olibanum 1---18 parts of 7 parts of Myrrhas 1---7 parts of Radix Angelicae Sinensis 3---
Radix Achyranthis Bidentatae 3---6 parts of 18 portions of Ganodermas 0.8---7 parts of Ganoderma spore powders 0.5---
18 parts of Herba sambuci chinensis 2---11 parts of Radix Rehmanniae 3---
The Chinese medicine of this treatment acromegaly necrosis diabetes is made by following method:
(1) by above-mentioned weight ratio, Herba Artemisiae Anomalae, Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Herba sambuci chinensis, the Radix Rehmanniae are extracted through conventional water extraction process, make extract powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma, Olibanum, Myrrha are ground into fine powder respectively, mix, stir with Ganoderma spore powder, above-mentioned (1) extractum fine powder; Can concoct and make Chinese medicine electuary, granule, capsule, powder, watered pill, tablets and other formulations according to a conventional method as required.
2, a kind of Chinese medicine as claimed in claim 1 is characterized in that: it is the Chinese medicine that is used for the treatment of acromegaly necrosis diabetes.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science blood circulation promoting and blood stasis dispelling develops meticulously; Purpose is effective, instant effect; Prescription Ganoderma QI invigorating alleviating distention in middle-JIAO of the present invention, the tonification the five internal organs; The Radix Rehmanniae, Chinese Angelica blood replonishing are invigorated blood circulation, Radix Achyranthis Bidentatae, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling; Tissue " necrosis ", acra " pain ", the disunion of festering are three difficult points of primary disease treatment, and non-general blood circulation promoting and blood stasis dispelling can solve; Therefore, compatibility Herba sambuci chinensis promoting blood circulation to remove blood stasis of the present invention is accelerated hematoma and is dissipated; The Herba Artemisiae Anomalae promoting blood circulation and detumescence, blood stasis dispelling and pain relieving; The Rhizoma Drynariae invigorating blood circulation analgesia has the kidney invigorating concurrently; Olibanum, Myrrha promoting blood circulation and stopping pain, detumescence and promoting granulation, useful acral necrosis organized renewing.Make a general survey of full side, all medicine compatibilities depend on each other for existence, and maximize favourable factors and minimize unfavourable ones, and bring out the best in each other, and benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain are used for the treatment of acromegaly necrosis diabetes, and it is definite to have drug effect, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Artemisiae Anomalae 30 gram Rhizoma Drynariae 30 gram Radix Notoginseng 20 grams
Olibanum 15 gram Myrrhas 15 gram Radix Angelicae Sinensis 40 grams
Radix Achyranthis Bidentatae 40 kairine sesames 8 kairine Ganoderma lucidum spore powder 5 grams
The Herba sambuci chinensis 30 gram Radix Rehmanniae 50 grams
Weight is extracted Herba Artemisiae Anomalae, Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Herba sambuci chinensis, the Radix Rehmanniae with conventional water extraction process in accordance with regulations, makes extractum fine powder 88 grams; Radix Notoginseng, Ganoderma, Olibanum, Myrrha are ground into fine powder respectively, mix, stir pelletize with Ganoderma spore powder and extractum fine powder; Adorn capsule No. 0, make 604 of capsules, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
2, get following prescription (weight is unit by gram):
Herba Artemisiae Anomalae 70 gram Rhizoma Drynariae 85 gram Radix Notoginseng 90 grams
Olibanum 40 gram Myrrhas 40 gram Radix Angelicae Sinensis 120 grams
Radix Achyranthis Bidentatae 110 kairine sesames 45 kairine Ganoderma lucidum spore powder 35 grams
The Herba sambuci chinensis 60 gram Radix Rehmanniae 120 grams
With above-mentioned same method, make 1904 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
3, get following prescription (weight is unit by gram):
Herba Artemisiae Anomalae 120 gram Rhizoma Drynariae 140 gram Radix Notoginseng 150 grams
Olibanum 70 gram Myrrhas 70 gram Radix Angelicae Sinensis 180 grams
Radix Achyranthis Bidentatae 180 kairine sesames 70 kairine Ganoderma lucidum spore powder 60 grams
Come to the gram Radix Rehmanniae 180 grams of dialling 110
With above-mentioned same method, make 3136 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
4, get following prescription (by weight):
5 parts of 3 portions of Radix Notoginseng of 3 parts of Rhizoma Drynariae of Herba Artemisiae Anomalae
5 parts of 2.5 parts of Radix Angelicae Sinensis of 2.5 parts of Myrrhas of Olibanum
2 parts of 2.5 parts of Ganoderma spore powders of 5 portions of Ganodermas of Radix Achyranthis Bidentatae
6 parts in 4 parts of Radix Rehmanniae of Herba sambuci chinensis
With above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
5, get following prescription (by weight):
13 parts of 12 portions of Radix Notoginseng of 10 parts of Rhizoma Drynariae of Herba Artemisiae Anomalae
16 parts of 7 parts of Radix Angelicae Sinensis of 7 parts of Myrrhas of Olibanum
5 parts of 6 parts of Ganoderma spore powders of 16 portions of Ganodermas of Radix Achyranthis Bidentatae
18 parts in 10 parts of Radix Rehmanniae of Herba sambuci chinensis
With above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.25 gram.
Clinical data:
The present invention is example with the acromegaly necrosis diabetes, through 35 routine clinical observations.Select the standard of acromegaly necrosis diabetes disease: emaciated physique, limbs are weak; Limbs are sent out cold, poor blood circulation, amyotrophy; The lower limb weak and faint pulse, intermittent claudication; Legs and feet skin rubefaction, blue, blackout, tissue necrosis; Numb limbs and tense tendons is suffered from the limb acrodynia; Suffer from limb acra ulcer, fester, flowing water is suppurated, disunion for a long time.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 16 examples, women's 19 examples do not have other serious disease, and the age is 49-76 year, 64.2 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, on one's body energetically; Limbs are warm, send out cool the disappearance; Skin color is progressively bleached (normal skin color) by black purple, and blood circulation obviously improves; Trouble acroanesthesia, acrodynia obviously alleviate; Acra fester alleviation, the healing.
2, effective: body constitution strengthens, on one's body energetically; Limbs are warm, and blood circulation improves; Numb limbs and tense tendons, pain are alleviated to some extent.
3, invalid: the symptom no change.
During clinical experiment, withdraw other medicines and health nutrient.Take Chinese medicinal capsule of the present invention, observing 90 days is a course of treatment.Instructions of taking: every day 3 times, each 3 capsules.Every capsules includes Chinese medicine fine powder and extract 0.25 gram, warm water delivery service after meal, symptom promptly has alleviation after 30 days, take 90 days after, symptom is obviously improved.35 philtrums of clinical experiment, produce effects 19 people, effective 14 people, invalid 2 people, total effective rate 94.3%.

Claims (1)

1. Chinese medicine for the treatment of acromegaly necrosis diabetes, it is characterized in that: it is that following row components in portion by weight is made, and its component proportioning is:
Herba Artemisiae Anomalae 2-12 part Rhizoma Drynariae 2-15 part Radix Notoginseng 2-15 part
Olibanum 1-7 part Myrrha 1-7 part Radix Angelicae Sinensis 3-18 part
Radix Achyranthis Bidentatae 3-18 part Ganoderma 0.8-7 part Ganoderma spore powder 0.5-6 part
Herba sambuci chinensis 2-11 part Radix Rehmanniae 3-18 part
This Chinese medicine is made by following method:
(1) by above-mentioned weight ratio, Herba Artemisiae Anomalae, Rhizoma Drynariae, Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Herba sambuci chinensis, the Radix Rehmanniae are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Olibanum, Myrrha, Ganoderma are ground into fine powder respectively, mix, stir with Ganoderma spore powder and extractum fine powder; Can be made into Chinese medicine granules, capsule, powder, watered pill, Tabules as required.
CN2007101221139A 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetes acral necrosis Expired - Fee Related CN101390985B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101221139A CN101390985B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetes acral necrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101221139A CN101390985B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetes acral necrosis

Publications (2)

Publication Number Publication Date
CN101390985A CN101390985A (en) 2009-03-25
CN101390985B true CN101390985B (en) 2010-11-10

Family

ID=40491626

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101221139A Expired - Fee Related CN101390985B (en) 2007-09-21 2007-09-21 Traditional Chinese medicine for treating diabetes acral necrosis

Country Status (1)

Country Link
CN (1) CN101390985B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552570B (en) * 2012-02-18 2013-07-17 孙步伟 Medicine for treating acra necrosis after bone trauma

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
张基栋.中药外洗治疗糖尿病并发急性神经痛46例.《实用中医内科杂志》.2000,第14卷(第3期),
张基栋.中药外洗治疗糖尿病并发急性神经痛46例.《实用中医内科杂志》.2000,第14卷(第3期). *
曲环汝等.苏励教授治疗类风湿性关节炎经验介绍.《新中医》.2004,第36卷(第3期),
曲环汝等.苏励教授治疗类风湿性关节炎经验介绍.《新中医》.2004,第36卷(第3期). *
赖祥林.活血化瘀法在骨科的临床应用新进展.《中国中医骨伤科杂志》.2005,第13卷(第2期),
赖祥林.活血化瘀法在骨科的临床应用新进展.《中国中医骨伤科杂志》.2005,第13卷(第2期). *

Also Published As

Publication number Publication date
CN101390985A (en) 2009-03-25

Similar Documents

Publication Publication Date Title
CN101843694B (en) Chinese medicament for treating chronic hepatitis
CN101530508B (en) Traditional Chinese medicine for treating ovarian cancer
CN101530461B (en) Traditional Chinese medicine for treating nasopharyngeal cancer
CN101390993B (en) Traditional Chinese medicine for treating diabetic foot
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN101390985B (en) Traditional Chinese medicine for treating diabetes acral necrosis
CN102380063A (en) Chinese medicament for treating diabetic foot
CN101850019A (en) Chinese medicament for treating diabetic acromelic gangrene
CN101884747B (en) Traditional Chinese medicine for treating chronic nephritis
CN102018765A (en) Traditional Chinese medicine for treating diabetic acromelic gangrene
CN101843706B (en) Chinese medicament for treating chronic kidney failure
CN101850078B (en) Chinese medicament for treating chronic nephritis
CN101554426B (en) Traditional Chinese medicine for treating diabetic obstipation
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN101843744B (en) Chinese medicament for treating chronic kidney failure
CN101843871B (en) Chinese medicament for treating diabetic acro-necrosis
CN101843870B (en) Chinese medicament for treating diabetic acro-necrosis
CN101518622B (en) Traditional Chinese medicine for treating diabetes complicated with urinary infection
CN101843826B (en) Chinese medicament for treating chronic kidney failure
CN101843756B (en) Chinese medicament for treating chronic nephritis
CN102379992A (en) Chinese medicament for treating diabetic diarrhea
CN102380067A (en) Traditional Chinese medicine for treating diabetic foot
CN101850020A (en) Chinese medicament for treating chronic kidney failure
CN101843866A (en) Chinese medicament for treating diabetic feet
CN101843767A (en) Chinese medicament for treating chronic kidney failure

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD.

Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD.

Effective date: 20130710

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130710

Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups

Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd.

Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602

Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd.

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20101110

Termination date: 20160921

CF01 Termination of patent right due to non-payment of annual fee